Arcadia Biosciences, Inc. — Director's Dealing 2016

Feb 29, 2016

SEC Form 3/A — Form 3/A

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-05-12

Reporting Person: Neal Wendy S. (VP, Chief Legal Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$1.08	2018-06-30	Common Stock (50000)		Direct

Footnotes

F1: The option is fully exercisable as of the date hereof.

F2: The Conversion or Exercise Price of Derivative Security originally reported in Table II, Column 4 of the Reporting Person's Form 3 filed May 12, 2015 was incorrectly reported to be $10.08. The purpose of this Amendment is to correct the Exercise Price to $1.08.